TY - JOUR TI - Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak AU - Stephen Gire AU - Augustine Goba AU - Kristian G. Andersen AU - Rachel Sealfon AU - Daniel J. Park AU - Lansana Kanneh AU - Simbirie Jalloh AU - Mambu Momoh AU - Mohamed Fullah AU - Gytis Dudas AU - Shirlee Wohl AU - Lina Moses AU - Nathan L. Yozwiak AU - S Winnicki AU - Christian B. Matranga AU - Christine M. Malboeuf AU - James Qu AU - Adrianne D. Gladden AU - S. F. Schaffner AU - Xiao Yang AU - Panpan Jiang AU - Mahan Nekoui AU - Andrés Colubri AU - Moinya Coomber AU - Mbalu Fonnie AU - Alex Moigboi AU - Michael Gbakie AU - Fatima Kamara AU - Veronica Tucker AU - Edwin Konuwa AU - Sidiki Saffa AU - Josephine Sellu AU - Abdul A. Jalloh AU - Alice Kovoma AU - James Koninga AU - Ibrahim Mustapha AU - Kandeh Kargbo AU - Momoh Foday AU - Mohamed Yillah AU - Franklyn Kanneh AU - Willie Robert AU - James L.B. Massally AU - Sinéad B. Chapman AU - James Bochicchio AU - Cheryl I. Murphy AU - Chad Nusbaum AU - Sarah Young AU - Susan J. Birren AU - Donald S. Grant AU - John S. Scheiffelin AU - Eric S. Lander AU - Christian Happi AU - Sahr M. Gevao AU - Andreas Gnirke AU - Andrew Rambaut AU - Robert F. Garry AU - Sheik Humarr Khan AU - Pardis C. Sabeti PY - 2014 JO - Science DO - 10.1126/science.1259657 UR - https://doi.org/10.1126/science.1259657 AB - In its largest outbreak, Ebola virus disease is spreading through Guinea, Liberia, Sierra Leone, and Nigeria. We sequenced 99 Ebola virus genomes from 78 patients in Sierra Leone to ~2000× coverage. We observed a rapid accumulation of interhost and intrahost genetic variation, allowing us to characterize patterns of viral transmission over the initial weeks of the epidemic. This West African variant likely diverged from central African lineages around 2004, crossed from Guinea to Sierra Leone in May 2014, and has exhibited sustained human-to-human transmission subsequently, with no evidence of additional zoonotic sources. Because many of the mutations alter protein sequences and other biologically meaningful targets, they should be monitored for impact on diagnostics, vaccines, and therapies critical to outbreak response. ER -